AstraZeneca enhances long-term growth through oncology investment in Acerta Pharma
|
17 December 2015 |
AstraZeneca to strengthen therapy area franchise through acquisition of Takeda's respiratory business
|
16 December 2015 |
AstraZeneca to harness power of the Secretome and develop next-generation biologics in collaboration with new Wallenberg Centre for Protein Research
|
11 December 2015 |
AstraZeneca and Voluntis to test companion mobile app in ovarian cancer studies with the US National Cancer Institute
|
08 December 2015 |
AstraZeneca enters into agreement with Perrigo for rights to Entocort® in the US
|
23 November 2015 |
AstraZeneca strengthens cardiovascular and metabolic disease portfolio with acquisition of ZS Pharma
|
06 November 2015 |
AstraZeneca and Lilly expand immuno-oncology research collaboration with new combinations
|
22 October 2015 |
New England Journal of Medicine publishes results of head-to-head studies of brodalumab versus ustekinumab in psoriasis
|
01 October 2015 |
AstraZeneca purchases US biologics manufacturing facility to support growing pipeline
|
11 September 2015 |
AstraZeneca to invest £11.5 million in new clinical oncology bioinformatics collaboration with The University of Manchester
|
08 September 2015 |